NCI, Division of Cancer Prevention Protocol Information Office

NCI，癌症预防方案信息办公室司

• 批准号: 7934153
• 负责人: WANDA BRYANT-DAVIS
• 金额: $ 55.95万
• 依托单位: EDJ ASSOCIATES, INC.
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-30 至 2010-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7934153
• 关键词: NCI; Division; Cancer; Prevention; Protocol

The Protocol Information Office (PIO) is an office in the Division of Cancer Prevention (DCP) that is responsible for central management of information about clinical trial activities. The PIO supports the mission of the Division by: -Serving as the central point of contact for information about clinical research funded by the Division. -Maintaining a central repository of all Division clinical trials documents and clinical trial-related information. -Coordinating the internal document review and response process for all clinical trials. -Developing and maintaining electronic information management tools to support DCP staff, contractors and extramural investigators. -Providing information regarding clinical trials and agents to assist the Division in program management and strategic planning. The PIO coordinates all administrative aspects related to clinical trial development to ensure that quality protocols are developed in the most expeditious and efficient manner possible. Toward that end, PIO collects, processes, tracks and monitors all protocol related information between DCP and its extramural collaborators (investigators, cooperative groups, cancer centers, FDA, pharmaceutical industry, and other NCI programs). The PIO tracks protocols from the first submission of the idea, through the review process, through the conduct of the study, to final completion.

方案信息办公室 (PIO) 是癌症预防司 (DCP) 的一个办公室，负责集中管理有关临床试验活动的信息。 PIO 通过以下方式支持该部门的使命： -作为该部门资助的临床研究信息的中心联络点。 -维护所有部门临床试验文件和临床试验相关信息的中央存储库。 -协调所有临床试验的内部文件审查和响应流程。 -开发和维护电子信息管理工具，以支持 DCP 工作人员、承包商和外部调查人员。 -提供有关临床试验和药物的信息，以协助该部门进行项目管理和战略规划。 PIO 协调与临床试验开发相关的所有管理方面，以确保以最迅速、最有效的方式制定质量方案。为此，PIO 收集、处理、跟踪和监控 DCP 与其外部合作者（研究人员、合作团体、癌症中心、FDA、制药行业和其他 NCI 项目）之间的所有协议相关信息。 PIO 跟踪协议从首次提交想法，到审查过程，再到研究的进行，直至最终完成。